MOHAMED AYAD: Open Payments
NPI 1417924309 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 86 payments from 22 companies in 2025. Trend: 2023 $1,545 · 2024 $1,611 · 2025 $1,713
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $248 |
| PFIZER INC. | 12 | $185 |
| Ardelyx, Inc. | 14 | $177 |
| Actelion Pharmaceuticals US, Inc. | 1 | $140 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Exact Sciences Corporation | 5 | $96 |
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| Indivior Inc. | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $71 |
| Sumitomo Pharma America, Inc. | 4 | $69 |
Products named: IBSRELA, UPTRAVI, ZENPEP, NURTEC ODT, Cologuard Collection Kit, SUBLOCADE, CAPLYTA, GEMTESA.
Industry payments across MI — which companies pay providers there.
